Charles Taylor v. HHS - Influenza, Guillain-Barré syndrome (GBS) (2025)
Case summary [AI summaries can sometimes make mistakes]
Charles Taylor, an adult, received an influenza vaccine on October 5, 2020. Within days, he began experiencing symptoms including fatigue, headaches, tingling in his hands and feet, and generalized weakness.
He was hospitalized and diagnosed with Guillain-Barré syndrome (GBS), an autoimmune disorder affecting the peripheral nervous system. The court found that his case met the criteria for a Table claim, meaning the vaccine is presumed to have caused the GBS.
The respondent argued that a cytomegalovirus (CMV) infection was the sole substantial cause, but the court found insufficient evidence to support this claim, concluding that the vaccine was a substantial factor in causing the GBS. The court awarded Mr.
Taylor $130,000 for actual pain and suffering, acknowledging the severity and duration of his GBS symptoms, which included a five-day hospitalization, a course of IVIg treatment, and residual weakness and numbness for approximately six months post-vaccination.
Theory of causation
Influenza vaccine on October 5, 2020, adult age stated in DB as 35, followed within days by fatigue, headache, tingling, weakness, hospitalization, and Guillain-Barre syndrome. COMPENSATED as a Table GBS case. Respondent argued cytomegalovirus infection was a factor unrelated/sole substantial cause, but Chief Special Master Corcoran found the record did not prove CMV displaced vaccine causation. Damages decision filed July 8, 2025 awarded $130,000 for pain and suffering. No unreimbursable expenses were included in the staged damages summary.
Source PDFs
USCOURTS-cofc-1_22-vv-00335